Literature DB >> 29501206

Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults.

Andrew J Foy1, John Mandrola2, Guodong Liu3, Gerald V Naccarelli4.   

Abstract

Prospective cohort studies involving older adults report an association of obesity and new-onset atrial fibrillation and atrial flutter. To assess this relation, we performed a longitudinal cohort study from January 1, 2006 to December 31, 2013, using a national claims database that tracks all inpatient, outpatient, and pharmacy claims data. The primary end point of new-onset atrial fibrillation was compared between obese and nonobese cohorts. We used logistic regression to determine the strength of association between obesity and new-onset atrial fibrillation controlling for age, gender, hypertension, and diabetes. Overall, 67,278 subjects were included in the cohort, divided evenly between those with and without a diagnosis of obesity. Obese subjects were significantly more likely to have hypertension (29.5% vs 14.6%) and diabetes (12.7% vs 5.2%) at study onset. Over 8 years of follow-up, we recorded a new diagnosis of atrial fibrillation in 1,511 (2.2%) subjects. Obesity was strongly associated with a new diagnosis of atrial fibrillation after controlling for age, gender, hypertension, and diabetes (odds ratio 1.4, 95% confidence interval 1.3 to 1.6). In conclusion, this information contributes to the growing evidence supporting the causal relation between obesity and atrial fibrillation, and emphasizes the need of addressing obesity as part of our therapeutic strategy to prevent atrial fibrillation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29501206     DOI: 10.1016/j.amjcard.2018.01.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Vaccination and risk of lone atrial fibrillation in the active component United States military.

Authors:  Michael M McNeil; Susan K Duderstadt; Jennifer F Sabatier; Gina G Ma; Jonathan Duffy
Journal:  Hum Vaccin Immunother       Date:  2019-01-08       Impact factor: 3.452

Review 2.  Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.

Authors:  Michael J Jamieson; Wonkyung Byon; Richard W Dettloff; Matthew Crawford; Peter S Gargalovic; Samira J Merali; Joelle Onorato; Andres J Quintero; Cristina Russ
Journal:  Am J Cardiovasc Drugs       Date:  2022-05-16       Impact factor: 3.571

3.  The Influence of Obesity on the Association of Obstructive Sleep Apnea and Atrial Fibrillation.

Authors:  Patrick L Stafford; Evan K Harmon; Paras Patel; McCall Walker; Gen-Min Lin; Seung-Jung Park; Neal A Chatterjee; Nishaki K Mehta; Sula Mazimba; Kenneth Bilchick; Younghoon Kwon
Journal:  Sleep Med Res       Date:  2021-06-24

4.  A Stronger Association of Epicardial Fat Volume with Non-Valvular Atrial Fibrillation Than Measures of General Obesity in Chinese Patients Undergoing Computed Tomography Coronary Angiography.

Authors:  Jingqi Zhu; Zhangwei Yang; Xiaoli Chen; Jie Liu; Liang Zheng; Lin Zhang; Jingjiang Pi; Gang Li; Tao Zhuang; Chang Liu; Yinglu Wang; Liping Liu; Lieying Fan; Paul Chan; Brian Tomlinson; Ying Li; Zhongmin Liu; Yuzhen Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-18       Impact factor: 3.168

5.  Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach.

Authors:  Lavinia-Lucia Matei; Calin Siliste; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2021-03

6.  The Influence of Surgical Weight Reduction on Left Atrial Strain.

Authors:  Jakub Strzelczyk; Piotr Kalinowski; Krzysztof Zieniewicz; Cezary Szmigielski; Michał Byra; Grzegorz Styczyński
Journal:  Obes Surg       Date:  2021-09-22       Impact factor: 4.129

7.  Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US).

Authors:  Jeffrey S Berger; François Laliberté; Akshay Kharat; Dominique Lejeune; Kenneth Todd Moore; Young Jung; Patrick Lefebvre; Veronica Ashton
Journal:  Adv Ther       Date:  2021-05-25       Impact factor: 3.845

Review 8.  Obesity and Atrial Fibrillation: Should We Screen for Atrial Fibrillation in Obese Individuals? A Comprehensive Review.

Authors:  Kyrillos N Ghattas; Shahbakht Ilyas; Reham Al-Refai; Reeju Maharjan; Liliana Diaz Bustamante; Safeera Khan
Journal:  Cureus       Date:  2020-09-15

9.  Occurrence of Arrhythmias in Women with Thyroid Cancer Receiving Suppressive Doses of Levothyroxine.

Authors:  Karol Kaziród-Wolski; Aldona Kowalska; Janusz Sielski; Magdalena Biskup-Frużyńska; Grzegorz Piotrowski
Journal:  Curr Oncol       Date:  2021-11-29       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.